Abstract
Background: Large-scale, high-throughput gene expression profiling (GEP) has enabled better prediction of patient responsiveness to targeted immunotherapy. However, this approach has mainly focused on tumor tissues, seldom on the blood.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
